Shenzhen Bioeasy Biotechnology Co., Ltd. (SHE:300942)

China · Delayed Price · Currency is CNY

9.41

+0.29 (3.18%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Food Rapid Testing Business	208.51M	198.03M	184.94M	182.53M	180.04M
Food Rapid Testing Business Growth	5.29%	7.08%	1.32%	1.38%	-19.85%
Animal Disease Detection	13.74M	8.39M	2.51M	-	-
Animal Disease Detection Growth	63.87%	233.80%	-	-	-
in Vitro Diagnostic Business	2.00M	47.69M	499.44M	415.01M	78.41M
in Vitro Diagnostic Business Growth	-95.81%	-90.45%	20.34%	429.27%	438.65%
Total	224.25M	254.11M	686.90M	597.54M	258.46M
Total Growth	-11.75%	-63.01%	14.95%	131.20%	8.06%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	130.92M	173.59M	383.43M	536.50M	162.75M
China Growth	-24.58%	-54.73%	-28.53%	229.65%	-15.09%
Foreign	93.33M	80.51M	303.46M	61.04M	95.71M
Foreign Growth	15.92%	-73.47%	397.14%	-36.22%	101.42%
Total	224.25M	254.11M	686.90M	597.54M	258.46M
Total Growth	-11.75%	-63.01%	14.95%	131.20%	8.06%

Source: S&P Global Market Intelligence.